{"id":"https://openalex.org/W2057067749","doi":"https://doi.org/10.1158/1078-0432.ccr-06-2779","title":"Phase I Evaluation of a Fully Human Anti\u2013\u03b1v Integrin Monoclonal Antibody (CNTO 95) in Patients with Advanced Solid Tumors","display_name":"Phase I Evaluation of a Fully Human Anti\u2013\u03b1v Integrin Monoclonal Antibody (CNTO 95) in Patients with Advanced Solid Tumors","alternate_titles":[],"publication_year":2007,"publication_date":"2007-04-01","ids":{"openalex":"https://openalex.org/W2057067749","doi":"https://doi.org/10.1158/1078-0432.ccr-06-2779","mag":"2057067749","pmid":"https://pubmed.ncbi.nlm.nih.gov/17404096"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-06-2779","doi":"https://doi.org/10.1158/1078-0432.ccr-06-2779","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-06-2779","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2057067749"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086373936","display_name":"Saifee Mullamitha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I4210089382","display_name":"Cancer Research UK Cambridge Center","ror":"https://ror.org/0068m0j38","country_code":"GB","type":"facility","lineage":["https://openalex.org/I241749","https://openalex.org/I2801316944","https://openalex.org/I4210089382"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Saifee A. Mullamitha","raw_affiliation_strings":["1Cancer Research UK and","Cancer Research UK Cambridge Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research UK and","institution_ids":["https://openalex.org/I2801316944"]},{"raw_affiliation_string":"Cancer Research UK Cambridge Institute","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I4210089382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072973989","display_name":"N.C. Ton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nhuan C. Ton","raw_affiliation_strings":["1Cancer Research UK and","Division of Cancer Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research UK and","institution_ids":["https://openalex.org/I2801316944"]},{"raw_affiliation_string":"Division of Cancer Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009215153","display_name":"Geoff J.M. Parker","orcid":"https://orcid.org/0000-0003-2934-2234","observed_orcids":["https://orcid.org/0000-0003-2934-2234"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Geoff J.M. Parker","raw_affiliation_strings":["3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028246201","display_name":"Alan Jackson","orcid":"https://orcid.org/0000-0002-1623-0383","observed_orcids":["https://orcid.org/0000-0002-1623-0383"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alan Jackson","raw_affiliation_strings":["3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070651503","display_name":"Peter J. Julyan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter J. Julyan","raw_affiliation_strings":["2Department of Medical Physics, Christie Hospital, Withington;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medical Physics, Christie Hospital, Withington;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075708776","display_name":"Caleb Roberts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Caleb Roberts","raw_affiliation_strings":["3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and","Division of Cancer Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"Division of Cancer Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111948690","display_name":"Gio A. Buonaccorsi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gio A. Buonaccorsi","raw_affiliation_strings":["3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112057932","display_name":"Yvonne Watson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yvonne Watson","raw_affiliation_strings":["3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080028611","display_name":"Karen E. Davies","orcid":"https://orcid.org/0000-0002-8983-8357","observed_orcids":["https://orcid.org/0000-0002-8983-8357"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Karen Davies","raw_affiliation_strings":["3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109202304","display_name":"Sue Cheung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sue Cheung","raw_affiliation_strings":["3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and","FBMH Technical Services (L5)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Imaging Science and Biomedical Engineering, University of Manchester, Manchester, United Kingdom; and","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"FBMH Technical Services (L5)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083006636","display_name":"Lynn Hope","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lynn Hope","raw_affiliation_strings":["1Cancer Research UK and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research UK and","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077826150","display_name":"Juan W. Valle","orcid":"https://orcid.org/0000-0002-1999-0863","observed_orcids":["https://orcid.org/0000-0002-1999-0863"]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Juan W. Valle","raw_affiliation_strings":["1Cancer Research UK and","Division of Cancer Sciences (L5)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research UK and","institution_ids":["https://openalex.org/I2801316944"]},{"raw_affiliation_string":"Division of Cancer Sciences (L5)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011398209","display_name":"John A. Radford","orcid":"https://orcid.org/0000-0001-7898-2786","observed_orcids":["https://orcid.org/0000-0001-7898-2786"]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John A. Radford","raw_affiliation_strings":["1Cancer Research UK and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research UK and","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048587251","display_name":"Jeremy Lawrance","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeremy Lawrance","raw_affiliation_strings":["1Cancer Research UK and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research UK and","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040081800","display_name":"Mark P. Saunders","orcid":"https://orcid.org/0000-0002-7195-4712","observed_orcids":["https://orcid.org/0000-0002-7195-4712"]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark P. Saunders","raw_affiliation_strings":["1Cancer Research UK and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research UK and","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081397248","display_name":"Mihaela C. Munteanu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mihaela C. Munteanu","raw_affiliation_strings":["4Department of Clinical Trial Management,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Clinical Trial Management,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108198815","display_name":"Marian T. Nakada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marian T. Nakada","raw_affiliation_strings":["5Oncology Discovery Research,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Oncology Discovery Research,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104256355","display_name":"Jeffrey A. Nemeth","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey A. Nemeth","raw_affiliation_strings":["5Oncology Discovery Research,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Oncology Discovery Research,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076610847","display_name":"Hugh M. Davis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hugh M. Davis","raw_affiliation_strings":["6Clinical Pharmacology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Clinical Pharmacology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110210397","display_name":"Qun Jiao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Qun Jiao","raw_affiliation_strings":["6Clinical Pharmacology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Clinical Pharmacology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086588343","display_name":"Uma Prabhakar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Uma Prabhakar","raw_affiliation_strings":["6Clinical Pharmacology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Clinical Pharmacology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112017868","display_name":"Zhihui Lang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Zhihui Lang","raw_affiliation_strings":["7Oncology Clinical Research and Development, Centocor Research and Development, Inc., Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Oncology Clinical Research and Development, Centocor Research and Development, Inc., Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079684551","display_name":"Robert E. Corringham","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert E. Corringham","raw_affiliation_strings":["7Oncology Clinical Research and Development, Centocor Research and Development, Inc., Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Oncology Clinical Research and Development, Centocor Research and Development, Inc., Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027438799","display_name":"Robert A. Beckman","orcid":"https://orcid.org/0000-0003-0098-9210","observed_orcids":["https://orcid.org/0000-0003-0098-9210"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert A. Beckman","raw_affiliation_strings":["7Oncology Clinical Research and Development, Centocor Research and Development, Inc., Malvern, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Oncology Clinical Research and Development, Centocor Research and Development, Inc., Malvern, Pennsylvania","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023247842","display_name":"Gordon C. Jayson","orcid":"https://orcid.org/0000-0002-8515-8944","observed_orcids":["https://orcid.org/0000-0002-8515-8944"]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gordon C. Jayson","raw_affiliation_strings":["1Cancer Research UK and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research UK and","institution_ids":["https://openalex.org/I2801316944"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":9.7369,"has_fulltext":false,"cited_by_count":157,"citation_normalized_percentile":{"value":0.98613552,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"13","issue":"7","first_page":"2128","last_page":"2135"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.8529999852180481,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.8529999852180481,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.10419999808073044,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.020600000396370888,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/integrin-alphav","display_name":"ITGAV","score":0.7459999918937683},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.871999979019165},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8669999837875366},{"id":"https://openalex.org/keywords/refractory-cancer","display_name":"refractory cancer","score":0.7110000252723694},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.6890000104904175},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9259999990463257},{"id":"https://openalex.org/keywords/cutaneous-angiosarcoma","display_name":"cutaneous angiosarcoma","score":0.8190000057220459},{"id":"https://openalex.org/keywords/ovarian-carcinosarcoma","display_name":"ovarian carcinosarcoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tumor-penetration","display_name":"tumor penetration","score":0.6340000033378601},{"id":"https://openalex.org/keywords/bcl-2-expression","display_name":"Bcl-2 expression","score":0.9459999799728394},{"id":"https://openalex.org/keywords/pharmacodynamic-activity","display_name":"pharmacodynamic activity","score":0.49399998784065247},{"id":"https://openalex.org/keywords/extended-dosing","display_name":"extended dosing","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8109628558158875},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.515059232711792},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.47946178913116455},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4605156183242798},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4497680962085724},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.384174108505249},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.35808950662612915},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.3310794234275818},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3225214183330536},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.25462549924850464},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1900956928730011}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D039564","descriptor_name":"Integrin alphaV","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D039564","descriptor_name":"Integrin alphaV","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D049268","descriptor_name":"Positron-Emission Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1078-0432.ccr-06-2779","doi":"https://doi.org/10.1158/1078-0432.ccr-06-2779","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-06-2779","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:17404096","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17404096","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/3cf6ef59-9c08-4174-8a4e-7053f91cf96b","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/3cf6ef59-9c08-4174-8a4e-7053f91cf96b","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mullamitha, SA, Ton, NC, Parker, GJ, Jackson, A, Julyan, PJ, Roberts, C, Buonaccorsi, GA, Watson, Y, Davies, K, Cheung, S, Valle, JW, Hope, L, Radford, JA, Lawrance, J, Saunders, MP, Munteanu, MC, Nakada, MT, Nemeth, JA, Davis, HM, Jiao, Q, Prabhaker, U, Lang, Z, Corringham, RE, Beckman, RA & Jayson, GC 2007, 'Phase I evaluation of a fully human ant-{alpha}v integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumours', Clinical Cancer Research, vol. 13, no. 2, pp. 128-135.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/7b6633a9-a7f2-444b-bbe4-29aa0b9e7d69","doi":null,"is_oa":false,"landing_page_url":"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17404096","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W155381746","https://openalex.org/W182385585","https://openalex.org/W1494507441","https://openalex.org/W1514170807","https://openalex.org/W1960270838","https://openalex.org/W1987739080","https://openalex.org/W1992844265","https://openalex.org/W2001753204","https://openalex.org/W2003366243","https://openalex.org/W2008181555","https://openalex.org/W2014825000","https://openalex.org/W2029773366","https://openalex.org/W2038939944","https://openalex.org/W2039317622","https://openalex.org/W2042098439","https://openalex.org/W2046507292","https://openalex.org/W2050423483","https://openalex.org/W2057936672","https://openalex.org/W2061350341","https://openalex.org/W2062245523","https://openalex.org/W2063037691","https://openalex.org/W2065637833","https://openalex.org/W2066521983","https://openalex.org/W2070992269","https://openalex.org/W2082800425","https://openalex.org/W2087963453","https://openalex.org/W2088056286","https://openalex.org/W2089513130","https://openalex.org/W2090873345","https://openalex.org/W2093227016","https://openalex.org/W2099303263","https://openalex.org/W2108713158","https://openalex.org/W2109069224","https://openalex.org/W2114682727","https://openalex.org/W2128373232","https://openalex.org/W2130872658","https://openalex.org/W2133390154","https://openalex.org/W2139248078","https://openalex.org/W2140338938","https://openalex.org/W2157769714","https://openalex.org/W2235703329","https://openalex.org/W2297929500","https://openalex.org/W2416711446","https://openalex.org/W4299665095","https://openalex.org/W4322717319"],"related_works":["https://openalex.org/W2296077249","https://openalex.org/W2062245523","https://openalex.org/W2225456875","https://openalex.org/W2488421165","https://openalex.org/W4214697329","https://openalex.org/W2089503722","https://openalex.org/W2587494737","https://openalex.org/W2099550296","https://openalex.org/W2099467058"],"abstract_inverted_index":{"PURPOSE:":[0],"A":[1,179],"fully":[2],"human":[3],"monoclonal":[4],"antibody":[5],"to":[6,14,97,126,170,200,204,216],"anti-alpha(v)":[7],"integrins":[8],"(CNTO":[9],"95)":[10],"has":[11],"been":[12],"shown":[13],"inhibit":[15],"angiogenesis":[16],"and":[17,27,52,62,64,73,116,149,168,243],"tumor":[18,154,167,171,241],"growth":[19],"in":[20,32,173,181,206],"preclinical":[21],"studies.":[22],"We":[23],"assessed":[24],"the":[25,102,129,166],"safety":[26],"pharmacokinetics":[28],"of":[29,113,119,165],"CNTO":[30,46,106,162,201,220],"95":[31,47,107,163,202,221],"patients":[33,131,227],"with":[34,110,140,175,186,234],"advanced":[35],"refractory":[36],"solid":[37],"tumors.":[38],"EXPERIMENTAL":[39],"DESIGN:":[40],"In":[41],"this":[42],"phase":[43],"I":[44],"trial,":[45],"(0.1,":[48],"0.3,":[49],"1.0,":[50],"3.0,":[51],"10.0":[53],"mg/kg)":[54,185],"was":[55,108,190,222],"infused":[56],"on":[57],"days":[58],"0,":[59],"28,":[60],"35,":[61],"42,":[63],"clinical":[65],"assessments,":[66],"dynamic":[67],"contrast-enhanced":[68],"magnetic":[69],"resonance":[70],"imaging":[71],"(DCE-MRI),":[72],"[(18)F]-2-fluorodeoxyglucose":[74],"positron":[75],"emission":[76],"tomography":[77],"(FDG-PET)":[78],"were":[79,87],"done.":[80],"Patients":[81],"achieving":[82],"stable":[83,187],"disease":[84],"or":[85],"better":[86],"eligible":[88],"for":[89,95],"extended":[90,134,229],"dosing":[91],"every":[92],"3":[93],"weeks":[94],"up":[96],"12":[98],"months.":[99],"RESULTS:":[100],"Among":[101],"24":[103],"enrolled":[104],"patients,":[105],"associated":[109],"one":[111,136,182,232],"episode":[112],"grade":[114,120],"III":[115],"four":[117],"episodes":[118],"II":[121],"infusion-related":[122],"fever":[123],"(all":[124],"responded":[125],"acetaminophen).":[127],"Of":[128],"six":[130],"who":[132],"received":[133,228],"dosing,":[135],"patient":[137,183,233],"(10.0":[138,184],"mg/kg),":[139],"cutaneous":[141],"angiosarcoma,":[142],"had":[143],"a":[144,207,235],"9-month":[145],"partial":[146],"response.":[147,237],"Pre-":[148],"post-treatment":[150],"lesion":[151,180],"biopsies":[152],"confirmed":[153,240],"cell":[155],"alpha(v)":[156],"integrin":[157],"expression,":[158],"as":[159,161],"well":[160,224],"penetration":[164],"localization":[169,242],"cells":[172],"association":[174],"reduced":[176],"bcl-2":[177],"expression.":[178],"ovarian":[188],"carcinosarcoma":[189],"no":[191],"longer":[192],"detectable":[193],"by":[194,196],"FDG-PET":[195],"day":[197],"49.":[198],"Exposure":[199],"seemed":[203],"increase":[205],"greater-than-dose-proportional":[208],"manner;":[209],"dose-dependent":[210],"mean":[211],"half-life":[212],"ranged":[213],"from":[214],"0.26":[215],"6.7":[217],"days.":[218],"CONCLUSIONS:":[219],"generally":[223],"tolerated.":[225],"Six":[226],"therapy,":[230],"including":[231],"prolonged":[236],"Biopsy":[238],"data":[239],"pharmacodynamic":[244],"activity.":[245]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2057067749","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":19}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
